|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for GSTO1 |
Basic gene info. | Gene symbol | GSTO1 |
Gene name | glutathione S-transferase omega 1 | |
Synonyms | GSTO 1-1|GSTTLp28|HEL-S-21|P28|SPG-R | |
Cytomap | UCSC genome browser: 10q25.1 | |
Genomic location | chr10 :106013951-106027222 | |
Type of gene | protein-coding | |
RefGenes | NM_001191002.1, NM_001191003.1,NM_004832.2, | |
Ensembl id | ENSG00000148834 | |
Description | GSTO-1MMA(V) reductaseS-(Phenacyl)glutathione reductaseepididymis secretory protein Li 21glutathione S-transferase omega 1-1glutathione S-transferase omega-1glutathione-S-transferase likeglutathione-dependent dehydroascorbate reductasemonomethylar | |
Modification date | 20141207 | |
dbXrefs | MIM : 605482 | |
HGNC : HGNC | ||
Ensembl : ENSG00000148834 | ||
HPRD : 10401 | ||
Vega : OTTHUMG00000019001 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_GSTO1 | |
BioGPS: 9446 | ||
Gene Expression Atlas: ENSG00000148834 | ||
The Human Protein Atlas: ENSG00000148834 | ||
Pathway | NCI Pathway Interaction Database: GSTO1 | |
KEGG: GSTO1 | ||
REACTOME: GSTO1 | ||
ConsensusPathDB | ||
Pathway Commons: GSTO1 | ||
Metabolism | MetaCyc: GSTO1 | |
HUMANCyc: GSTO1 | ||
Regulation | Ensembl's Regulation: ENSG00000148834 | |
miRBase: chr10 :106,013,951-106,027,222 | ||
TargetScan: NM_001191002 | ||
cisRED: ENSG00000148834 | ||
Context | iHOP: GSTO1 | |
cancer metabolism search in PubMed: GSTO1 | ||
UCL Cancer Institute: GSTO1 | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for GSTO1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: GSTO1 |
Familial Cancer Database: GSTO1 |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_GLUTATHIONE_METABOLISM KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 KEGG_DRUG_METABOLISM_CYTOCHROME_P450 REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS |
Others | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: GSTO1 |
MedGen: GSTO1 (Human Medical Genetics with Condition) | |
ClinVar: GSTO1 | |
Phenotype | MGI: GSTO1 (International Mouse Phenotyping Consortium) |
PhenomicDB: GSTO1 |
Mutations for GSTO1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows GSTO1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
AA234313 | CPD | 1 | 140 | 17 | 28758847 | 28766081 | GSTO1 | 131 | 383 | 10 | 106019490 | 106025928 | |
BG314836 | GSTO1 | 6 | 183 | 10 | 106014951 | 106019431 | PLIN2 | 175 | 556 | 9 | 19115888 | 19116268 | |
BC082963 | HS3ST3A1 | 22 | 2058 | 17 | 13399487 | 13505235 | GSTO1 | 2058 | 2858 | 10 | 106014662 | 106027213 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   |   |   |   |   |   | 1 |   |   |   |   |   |   |   |   |   |   | |||
GAIN (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   | 1 |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=8) | (# total SNVs=2) |
(# total SNVs=0) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr10:106022834-106022836 | p.? | 3 |
chr10:106022789-106022789 | p.A140D | 1 |
chr10:106022834-106022834 | p.E155V | 1 |
chr10:106014943-106014943 | p.V19V | 1 |
chr10:106025846-106025846 | p.L157P | 1 |
chr10:106014984-106014984 | p.P33L | 1 |
chr10:106025851-106025851 | p.N159D | 1 |
chr10:106015023-106015023 | p.G46E | 1 |
chr10:106025864-106025864 | p.T163I | 1 |
chr10:106019360-106019360 | p.K57T | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 | 1 |   | 1 |   |   | 3 |   |   |   |   |   | 1 |   |   |   | 2 |   |   | 3 |
# mutation | 1 | 1 |   | 1 |   |   | 3 |   |   |   |   |   | 1 |   |   |   | 2 |   |   | 3 |
nonsynonymous SNV | 1 |   |   | 1 |   |   | 2 |   |   |   |   |   | 1 |   |   |   | 2 |   |   | 3 |
synonymous SNV |   | 1 |   |   |   |   | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr10:106025846 | p.D176N,GSTO1 | 1 |
chr10:106025864 | p.V19V,GSTO1 | 1 |
chr10:106027036 | p.P20P,GSTO1 | 1 |
chr10:106014943 | p.P33L,GSTO1 | 1 |
chr10:106027062 | p.K57T,GSTO1 | 1 |
chr10:106014946 | p.G80S,GSTO1 | 1 |
chr10:106014984 | p.E85K,GSTO1 | 1 |
chr10:106019360 | p.L98F,GSTO1 | 1 |
chr10:106019428 | p.R104K,GSTO1 | 1 |
chr10:106019443 | p.L124P,GSTO1 | 1 |
Other DBs for Point Mutations |
Copy Number for GSTO1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for GSTO1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
BLOC1S1,C19orf43,COX4I1,EDF1,EXOSC1,GADD45GIP1,GPX1, GSTO1,LOC100270710,MRPL23,LINC00152,NDUFA11,NDUFB8,PFDN5, PSMB6,RHOG,RNASEK,RPL24,RPLP2,TNFSF12-TNFSF13,USMG5 | ARPC2,ATP6V1F,AKIP1,C17orf49,CAPZB,GABARAP,GSTO1, IFI27L2,JTB,LST1,NENF,NPC2,NUTF2,PFN1, RBX1,RHOG,SCNM1,SH3BGRL3,SNRPG,TMSB10,TRAPPC1 | ||||
ASNA1,FAM204A,COX7A2,GADD45GIP1,GLRX3,GPX1,GSTO1, LSM2,MED31,MRPL43,MRPL54,MYEOV2,NDUFA11,NDUFA13, NDUFB7,NDUFB8,PFDN5,SNRPG,TIMM8B,TOMM22,VPS29 | BET1,COX14,IFT43,CHCHD2,CKLF,DYNLT1,GLO1, GSTO1,IFT20,LSM1,MYEOV2,NDUFB6,POLR2C,PSMA2, PSMA6,PSMA7,PSMB1,PSMB4,PSMD8,PSMD9,RNF181 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for GSTO1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00143 | glutathione S-transferase omega 1 | approved; nutraceutical | Glutathione | ||
DB00515 | glutathione S-transferase omega 1 | approved | Cisplatin | ||
DB01169 | glutathione S-transferase omega 1 | approved; investigational | Arsenic trioxide |
Top |
Cross referenced IDs for GSTO1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |